Phillip A Scott

Summary

Affiliation: University of Michigan
Country: USA

Publications

  1. doi request reprint A multilevel intervention to increase community hospital use of alteplase for acute stroke (INSTINCT): a cluster-randomised controlled trial
    Phillip A Scott
    Department of Emergency Medicine, University of Michigan, Ann Arbor, MI, USA
    Lancet Neurol 12:139-48. 2013
  2. pmc Attitudes and beliefs of Michigan emergency physicians toward tissue plasminogen activator use in stroke: baseline survey results from the INcreasing Stroke Treatment through INteractive behavioral Change Tactic (INSTINCT) trial hospitals
    Phillip A Scott
    Department of Emergency Medicine, University of Michigan, 24 Frank Lloyd Wright Drive, PO Box 381, Ann Arbor, MI 48106 0381, USA
    Stroke 41:2026-32. 2010
  3. pmc Enhancing community delivery of tissue plasminogen activator in stroke through community-academic collaborative clinical knowledge translation
    Phillip A Scott
    Department of Emergency Medicine, University of Michigan, Ann Arbor, MI 48106 0381, USA
    Emerg Med Clin North Am 27:115-36, ix. 2009
  4. pmc Safety of intravenous thrombolytic use in four emergency departments without acute stroke teams
    Phillip A Scott
    Department of Emergency Medicine, University of Michigan, Ann Arbor, USA
    Acad Emerg Med 17:1062-71. 2010
  5. pmc Lack of association between hyperglycaemia at arrival and clinical outcomes in acute stroke patients treated with tissue plasminogen activator
    William J Meurer
    Department of Emergency Medicine, University of Michigan, Ann Arbor, MI, USA
    Int J Stroke 5:163-6. 2010
  6. pmc Provider perceptions of barriers to the emergency use of tPA for acute ischemic stroke: a qualitative study
    William J Meurer
    Department of Emergency Medicine, University of Michigan, Ann Arbor, Michigan, USA
    BMC Emerg Med 11:5. 2011
  7. pmc Lack of association between pretreatment neurology consultation and subsequent protocol deviation in tissue plasminogen activator-treated patients with stroke
    William J Meurer
    Department of Emergency Medicine, University of Michigan, Ann Arbor, Mich, USA
    Stroke 41:2098-101. 2010
  8. doi request reprint Combined approach to lysis utilizing eptifibatide and recombinant tissue plasminogen activator in acute ischemic stroke-enhanced regimen stroke trial
    Arthur M Pancioli
    Department of Emergency Medicine, University of Cincinnati Neuroscience Institute, Cincinnati, OH, USA
    Stroke 44:2381-7. 2013
  9. pmc Antihypertensive treatment prolongs tissue plasminogen activator door-to-treatment time: secondary analysis of the INSTINCT trial
    Lesli E Skolarus
    Department of Biostatics, University of Michigan, School of Public Health, 1500 East Medical Center, Ann Arbor, MI 48109 5855, USA
    Stroke 43:3392-4. 2012
  10. pmc Does preexisting antiplatelet treatment influence postthrombolysis intracranial hemorrhage in community-treated ischemic stroke patients? An observational study
    William J Meurer
    Department of Emergency Medicine, University of Michigan, Ann Arbor, MI, USA
    Acad Emerg Med 20:146-54. 2013

Detail Information

Publications20

  1. doi request reprint A multilevel intervention to increase community hospital use of alteplase for acute stroke (INSTINCT): a cluster-randomised controlled trial
    Phillip A Scott
    Department of Emergency Medicine, University of Michigan, Ann Arbor, MI, USA
    Lancet Neurol 12:139-48. 2013
    ..Several types of barrier frequently prevent its use. We assessed whether a standardised, barrier-assessment, multicomponent intervention could increase alteplase use in community hospitals in Michigan, USA...
  2. pmc Attitudes and beliefs of Michigan emergency physicians toward tissue plasminogen activator use in stroke: baseline survey results from the INcreasing Stroke Treatment through INteractive behavioral Change Tactic (INSTINCT) trial hospitals
    Phillip A Scott
    Department of Emergency Medicine, University of Michigan, 24 Frank Lloyd Wright Drive, PO Box 381, Ann Arbor, MI 48106 0381, USA
    Stroke 41:2026-32. 2010
    ..The objective of this study was to determine the baseline proportion of emergency physicians with favorable attitudes and beliefs toward intravenous tissue plasminogen activator (tPA) use in a cohort of randomly selected Michigan hospitals...
  3. pmc Enhancing community delivery of tissue plasminogen activator in stroke through community-academic collaborative clinical knowledge translation
    Phillip A Scott
    Department of Emergency Medicine, University of Michigan, Ann Arbor, MI 48106 0381, USA
    Emerg Med Clin North Am 27:115-36, ix. 2009
    ..It reviews knowledge translation concepts and theory and explores practical community-academic collaborative methods based on these tenets to enhance acute stroke care delivery in the community setting...
  4. pmc Safety of intravenous thrombolytic use in four emergency departments without acute stroke teams
    Phillip A Scott
    Department of Emergency Medicine, University of Michigan, Ann Arbor, USA
    Acad Emerg Med 17:1062-71. 2010
    ..The objective was to evaluate safety of intravenous (IV) tissue plasminogen activator (tPA) delivered without dedicated thrombolytic stroke teams...
  5. pmc Lack of association between hyperglycaemia at arrival and clinical outcomes in acute stroke patients treated with tissue plasminogen activator
    William J Meurer
    Department of Emergency Medicine, University of Michigan, Ann Arbor, MI, USA
    Int J Stroke 5:163-6. 2010
    ..Hyperglycaemia is associated with adverse outcomes in some studies of acute ischaemic stroke...
  6. pmc Provider perceptions of barriers to the emergency use of tPA for acute ischemic stroke: a qualitative study
    William J Meurer
    Department of Emergency Medicine, University of Michigan, Ann Arbor, Michigan, USA
    BMC Emerg Med 11:5. 2011
    ..Provider barriers to adhering with guidelines recommending tPA delivery in acute stroke are not well known. The main objective of this study was to describe barriers to thrombolytic use in acute stroke care...
  7. pmc Lack of association between pretreatment neurology consultation and subsequent protocol deviation in tissue plasminogen activator-treated patients with stroke
    William J Meurer
    Department of Emergency Medicine, University of Michigan, Ann Arbor, Mich, USA
    Stroke 41:2098-101. 2010
    ..We evaluated the hypothesis that consultation with neurology would be associated with fewer protocol deviations in tissue plasminogen activator-treated patients with stroke...
  8. doi request reprint Combined approach to lysis utilizing eptifibatide and recombinant tissue plasminogen activator in acute ischemic stroke-enhanced regimen stroke trial
    Arthur M Pancioli
    Department of Emergency Medicine, University of Cincinnati Neuroscience Institute, Cincinnati, OH, USA
    Stroke 44:2381-7. 2013
    ..The Combined Approach to Lysis Utilizing Eptifibatide and rt-PA in Acute Ischemic Stroke-Enhanced Regimen (CLEAR-ER) trial sought to determine the safety of a higher-dose regimen and to establish evidence for a phase III trial...
  9. pmc Antihypertensive treatment prolongs tissue plasminogen activator door-to-treatment time: secondary analysis of the INSTINCT trial
    Lesli E Skolarus
    Department of Biostatics, University of Michigan, School of Public Health, 1500 East Medical Center, Ann Arbor, MI 48109 5855, USA
    Stroke 43:3392-4. 2012
    ..Identifying modifiable tissue plasminogen activator treatment delays may improve stroke outcomes. We hypothesized that prethrombolytic antihypertensive treatment (AHT) may prolong door-to-treatment time (DTT)...
  10. pmc Does preexisting antiplatelet treatment influence postthrombolysis intracranial hemorrhage in community-treated ischemic stroke patients? An observational study
    William J Meurer
    Department of Emergency Medicine, University of Michigan, Ann Arbor, MI, USA
    Acad Emerg Med 20:146-54. 2013
    ..The primary hypothesis was that antiplatelet use would not be associated with radiographic evidence of ICH after controlling for relevant confounders...
  11. ncbi request reprint Misdiagnosis of stroke in tissue plasminogen activator-treated patients: characteristics and outcomes
    Phillip A Scott
    Department of Emergency Medicine, University of Michigan, Ann Arbor, MI 48109 0303, USA
    Ann Emerg Med 42:611-8. 2003
    ..We report an evaluation of emergency department misdiagnoses in patients treated with tissue plasminogen activator for acute ischemic stroke...
  12. ncbi request reprint Determining intravenous rt-PA eligibility in the Emergency Department
    Amy C Mecozzi
    Stroke Program, University of Michigan Medical School, TC 1920 0316, 1500 East Medical Center Drive, Ann Arbor, MI 48109, USA
    Neurocrit Care 7:103-8. 2007
    ..The purpose of this study was to assess the agreement of Emergency Department (ED) attendings, ED residents, and neurology residents compared with stroke neurologists in the assessment of intravenous rt-PA eligibility...
  13. doi request reprint Time to brain imaging in acute stroke is improving: secondary analysis of the INSTINCT trial
    Kori Sauser
    From the Robert Wood Johnson Foundation Clinical Scholars Program K S, J F B, Department of Emergency Medicine K S, P A S, W J M, HSR and D Center for Clinical Management Research, Veterans Affairs Ann Arbor Healthcare System K S, J F B, D A L, Department of Neurology J F B, D A L, W J M, and Department of Internal Medicine D A L, University of Michigan, Ann Arbor
    Stroke 45:287-9. 2014
    ..Second, we examined the variation in DIT accounted for by patient-level and hospital-level factors...
  14. pmc Resource utilization and outcome at a university versus a community teaching hospital in tPA treated stroke patients: a retrospective cohort study
    Angela F Caveney
    Department of Psychiatry, University of Michigan, Commonwealth Blvd, Ann Arbor, MI, USA
    BMC Health Serv Res 10:44. 2010
    ....
  15. pmc The impact of emergency physician turnover on planning for prospective clinical trials
    William J Meurer
    University of Michigan Medical School, Department of Emergency Medicine, Ann Arbor, Michigan University of Michigan Medical School, Department of Neurology, Ann Arbor, Michigan
    West J Emerg Med 14:16-22. 2013
    ..We sought to determine the incidence and factors associated with EP workforce changes...
  16. ncbi request reprint Cost-effectiveness of helicopter transport of stroke patients for thrombolysis
    Robert Silbergleit
    Department of Emergency Medicine and Survival Flight, University of Michigan, Ann Arbor, MI 48109, USA
    Acad Emerg Med 10:966-72. 2003
    ..Helicopter transport for these patients has been described but without analysis of the effects of its additional cost. The authors examined the cost-effectiveness of helicopter transport for patients with acute stroke...
  17. ncbi request reprint Qualitative data collection and analysis methods: the INSTINCT trial
    William J Meurer
    Department of Emergency Medicine, University of Michigan, Ann Arbor, MI, USA
    Acad Emerg Med 14:1064-71. 2007
    ..The qualitative findings subsequently direct the form of professional education efforts and system interventions at treatment sites...
  18. doi request reprint National trends in use of computed tomography in the emergency department
    Keith E Kocher
    Department of Emergency Medicine, University of Michigan, Ann Arbor, MI, USA
    Ann Emerg Med 58:452-62.e3. 2011
    ..The role of computed tomography (CT) in acute illnesses has increased substantially in recent years; however, little is known about how CT use in the emergency department (ED) has changed over time...
  19. ncbi request reprint Prevalence of atrial fibrillation and antithrombotic prophylaxis in emergency department patients
    Phillip A Scott
    Department of Emergency Medicine, University of Michigan, Ann Arbor 48109, USA
    Stroke 33:2664-9. 2002
    ..This study evaluates that potential by determining the prevalence of AF in an ED population and assessing antithrombotic use in those patients with recurrent AF...
  20. ncbi request reprint Recovery of cognitive function after surgery for aneurysmal subarachnoid hemorrhage
    Satwant K Samra
    Department of Anesthesiology, University of Michigan Medical Center, University Hospital, Ann Arbor, MI 48109 0048, USA
    Stroke 38:1864-72. 2007
    ..We determined these in a subset of subarachnoid hemorrhage patients enrolled in the Intraoperative Hypothermia for Aneurysm Surgery Trial (IHAST)...